Author reply to "Heterologous mRNA-based COVID-19 booster strategies: Comment". | Hum Vaccin Immunother;19(1): 2195333, 2023 Dec 31. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Author reply to "Heterologous mRNA-based COVID-19 booster strategies: Comment".

Das, Rituparna; Hyer, Randall N; Burton, Paul; Miller, Jacqueline M; Kuter, Barbara J.

Affiliation

Das R; Moderna, Inc, Cambridge, MA, USA.
Hyer RN; Baruch S. Blumberg Institute, Doylestown, PA, USA.
Burton P; Moderna, Inc, Cambridge, MA, USA.
Miller JM; Moderna, Inc, Cambridge, MA, USA.
Kuter BJ; Moderna, Inc, Cambridge, MA, USA.

Hum Vaccin Immunother ; 19(1): 2195333, 2023 Dec 31.

Article in En | MEDLINE | ID: mdl-37014359

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Hum Vaccin Immunother Year: 2023 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Hum Vaccin Immunother Year: 2023 Document type: Article Affiliation country: United States Country of publication: United States